Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (11): 1223-1228.

Previous Articles     Next Articles

Construction of recombinant adenovirus containing tumor -targeting fusion RGD-IL-24 gene and analysis of its activity in vitro

YANG Jun1, LUO Jing-jing2, HU Xiu-fang2   

  1. 1Zhejiang Medical College, Hangzhou 310053,Zhejiang,China;
    2School of Life Sciences, Zhejiang Sci-Tech University,Hangzhou 310018, Zhejiang, China
  • Received:2010-07-17 Revised:2010-11-19 Online:2010-11-26 Published:2020-09-16

Abstract: AIM: To construct the recombinant adenovirus encoding tumor-targeting fusion RGD-IL-24 gene, and to study its biological activity in vitro. METHODS: The fusion gene GRGDS fused with N-terminus of IL-24 was obtained by PCR. Then it was cloned into the shuttle plasmid pAdTrack-CMV to form the transfer vector by the method of homogenous recombination in bacteria. The recombinant adenovirus was transfected into 293 cells using Lipofectine DOTAP.The target gene was detected by PCR. The titer and its infection rate were determined using the green fluorescent protein(GFP) expression in the shuttle plasmid.The activity of inducing tumor cells apoptosis was confirmed by MTT assay and Hoechst assay in vitro. RESULTS: The recombinant adenovirus vector was successfully constructed. The titer of the recombinant adenovirus was 1.3×1012 pfu/mL. Ad.RGD-IL-24 induced apoptosis of MCF-7 cells, and RGD-IL-24 was targeted to tumor cells in vitro. CONCLUSION: The recombinant adenovirus containing RGD-IL-24 gene is successfully constructed by the method of homogenous recombination in bacteria.

Key words: Interleukin-24, Adenovirus, Tumor targeting, Anti-tumor activity

CLC Number: